» Articles » PMID: 31006978

Impacts of Carbohydrate-restricted Diets on Micronutrient Intakes and Status: A Systematic Review

Overview
Journal Obes Rev
Specialty Endocrinology
Date 2019 Apr 23
PMID 31006978
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

A systematic review of published evidence on micronutrient intake/status with carbohydrate-restricted diets (CRD) was conducted in Web of Science, Medline, Embase, Scopus, CENTRAL, and ClinicalTrials.gov up to October 2018. We identified 10 studies: seven randomized controlled trials (RCTs) ("Atkins"-style, n = 5; "Paleolithic" diets, n = 2), two Atkins-style noncontrolled trials and one cross-sectional study. Prescribed carbohydrate varied 4% to 34% of energy intake. Only one noncontrolled trial prescribed multivitamin supplements. Dietary intakes/status were reported over 2 to 104 weeks, with weight losses from 2 to 9 kg. No diagnoses of deficiency were reported. Intakes of thiamine, folate, magnesium, calcium, iron, and iodine all decreased significantly (-10% to -70% from baseline) with any CRD types. Atkins diet trials (n = 6; 4%-34%E carbohydrate) showed inconsistent changes in vitamin A, E, and β-carotene intakes, while a single "Paleolithic" diet trial (28%E carbohydrate) reported increases in these micronutrients. One other "Paleolithic" diet (30%E carbohydrate) reported a rise in moderate iodine deficiency from 15% to 73% after 6 months. In conclusion, few studies have assessed the impacts of CRD on micronutrients. Studies with different designs point towards reductions in several vitamins and minerals, with potential risk of micronutrient inadequacies. Trial reporting standards are expected to include analysis of micronutrient intake/status. Micronutrients in foods and/or supplements should be considered when designing, prescribing or following CRDs.

Citing Articles

Low-carbohydrate diet for people with type 2 diabetes mellitus.

Burgos M, Ivaldi D, Oltra G, Escobar Liquitay C, Garegnani L Cochrane Database Syst Rev. 2025; 5:CD015954.

PMID: 39908069 PMC: 11131143. DOI: 10.1002/14651858.CD015954.


Therapeutic Potential of Ketogenic Interventions for Autosomal-Dominant Polycystic Kidney Disease: A Systematic Review.

Li D, Dawson J, Gunton J Nutrients. 2025; 17(1.

PMID: 39796576 PMC: 11723166. DOI: 10.3390/nu17010145.


Effect of a Modern Palaeolithic Diet in Combination with a Sprint Interval Training on Metabolic and Performance-Related Parameters in Male Athletes: A Pilot Trial.

Zdzieblik D, Waldvogel T, Zierke A, Gollhofer A, Konig D Nutr Metab Insights. 2024; 17:11786388241299896.

PMID: 39687599 PMC: 11648029. DOI: 10.1177/11786388241299896.


Clinical research framework proposal for ketogenic metabolic therapy in glioblastoma.

Duraj T, Kalamian M, Zuccoli G, Maroon J, DAgostino D, Scheck A BMC Med. 2024; 22(1):578.

PMID: 39639257 PMC: 11622503. DOI: 10.1186/s12916-024-03775-4.


Ketogenic diet in clinical populations-a narrative review.

Zemer A, Samaei S, Yoel U, Biderman A, Pincu Y Front Med (Lausanne). 2024; 11:1432717.

PMID: 39534224 PMC: 11554467. DOI: 10.3389/fmed.2024.1432717.